| Therapeutic Area(s) | Oncology |
Pancreatic cancer instigates in the tissues of pancreas — an organ in the abdomen that lies horizontally behind the lower part of the stomach. Pancreas releases enzymes and hormones, which help in digestion and maintaining blood sugar level in the body.
| Therapeutic Area(s) | Neurology |
Tosymra, previously known as DFN-02, an intranasal spray containing sumatriptan (10 mg) and a 5-HT1B/1D receptor agonist developed by Dr. Reddy’s Laboratories Limited and its subsidiary Promius Pharma, LLC, is approved by the USFDA in January, 2019 for the acute migraine.
| Therapeutic Area(s) | Others |
Osphena (Ospemifene), an estrogen receptor agonist with tissue selective effects. It is prescribed for painful intercourse (dyspareunia), which is a major symptom of vulvular and vagina muscular wasting (vaginal atrophy), due to menopause.
| Therapeutic Area(s) | OncologyOthers |
Dasatinib (Sprycel) medicines are generally used to treat people with chronic myeloid leukemia and people with acute lymphoblastic leukemia who have been tested positive for the Philadelphia chromosome (Ph+).